Dietary phosphorus restriction can prevent the progression of renal failure in subtotally
nephrectomized rats or in rats with nephrotoxic serum nephritis, independent of protein and …

Abstract Background/Aims: Hyperphosphatemia is an important clinical consequence of
renal failure, and its multiple adverse systemic effects are associated with significantly …

Hyperphosphatemia is a common complication in patients with chronic kidney disease
(CKD), particularly in those requiring renal replacement therapy. The importance of …

The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

Phosphorus is a well-known modulator of renal 1 alpha-hydroxylase activity. In early and
moderate renal failure it is proposed that dietary Pi reduction ameliorates secondary …

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease.
Secondary hyperparathyroidism in chronic renal disease appears to begin with the first …

Hypophosphatemia caused by renal phosphate loss occurs frequently after kidney
transplantation. In assumption of systemic phosphorus depletion, the presumed deficit …

Control of hyperphosphatemia in renal failure is often difficult to achieve. Although calcium-
containing phosphate binders have become the preferred phosphate binders, many patients …

Serum phosphorus levels stay relatively constant through the influence of multiple factors—
such as parathyroid hormone, fibroblast growth factor 23, and vitamin D—on the kidney …

Current evidence regarding the clinical consequences of hypophosphatemia is not
straightforward. Given the potentially different implications of hypophosphatemia among …